UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ICLR icon
501
Icon
ICLR
$13B
$1.36M 0.03%
7,017
+507
+8% +$101K
2022 Q2
2 quarters
SLN icon
502
Silence Therapeutics
SLN
$558M
$1.36M 0.03%
88,936
+9,300
+12% +$122K
2022 Q2
2 quarters
SRE icon
503
Sempra
SRE
$53.6B
$1.35M 0.03%
17,516
-45,370
-72% -$3.51M
2022 Q3
1 quarter
CRL icon
504
Charles River Laboratories
CRL
$14.4B
$1.34M 0.02%
+6,174
New +$1.35M
2022 Q4
0 quarters
HLVX icon
505
DELISTED
HilleVax
HLVX
$1.33M 0.02%
79,367
+18,424
+30% +$333K
2022 Q2
2 quarters
ALB icon
506
Albemarle
ALB
$11.6B
$1.31M 0.02%
+6,046
New +$1.61M
2022 Q4
0 quarters
NRG icon
507
NRG Energy
NRG
$21.2B
$1.31M 0.02%
41,098
+14,475
+54% +$573K
2022 Q1
3 quarters
COLD icon
508
Americold
COLD
$3.94B
$1.27M 0.02%
+44,808
New +$1.21M
2022 Q4
0 quarters
PTCT icon
509
PTC Therapeutics
PTCT
$4.98B
$1.25M 0.02%
+32,655
New +$1.36M
2022 Q4
0 quarters
EWTX icon
510
Edgewise Therapeutics
EWTX
$4.02B
$1.22M 0.02%
136,636
+25,886
+23% +$243K
2022 Q2
2 quarters
RWT icon
511
Redwood Trust
RWT
$371M
$1.22M 0.02%
180,653
-335,985
-65% -$2.35M
2021 Q2
6 quarters
NLY icon
512
Annaly Capital Management
NLY
$13.7B
$1.21M 0.02%
+57,487
New +$1.13M
2022 Q4
0 quarters
GTLS icon
513
DELISTED
Chart Industries
GTLS
$1.21M 0.02%
10,513
-12,437
-54% -$2M
2022 Q3
1 quarter
ITOS icon
514
DELISTED
iTeos Therapeutics
ITOS
$1.21M 0.02%
62,000
+4,500
+8% +$87.9K
2022 Q1
3 quarters
TRIS icon
515
DELISTED
Tristar Acquisition I Corp.
TRIS
$1.21M 0.02%
119,545
-1,170
-1% -$11.7K
2021 Q4
4 quarters
QFTA
516
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$1.2M 0.02%
119,225
-1,167
-1% -$11.6K
2022 Q1
3 quarters
ADPT icon
517
Adaptive Biotechnologies
ADPT
$4.09B
$1.17M 0.02%
153,082
+9,592
+7% +$74.6K
2022 Q1
3 quarters
SRRK icon
518
Scholar Rock
SRRK
$4.82B
$1.17M 0.02%
129,101
+19,851
+18% +$159K
2022 Q2
2 quarters
SBRA icon
519
Sabra Healthcare REIT
SBRA
$4.9B
$1.17M 0.02%
93,713
-158,076
-63% -$2.02M
2022 Q2
2 quarters
NEE icon
520
NextEra Energy
NEE
$163B
$1.16M 0.02%
13,925
-39,137
-74% -$3.16M
2022 Q2
2 quarters
MORF icon
521
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.16M 0.02%
43,383
+6,849
+19% +$187K
2022 Q1
3 quarters
ROIV icon
522
Roivant Sciences
ROIV
$24.3B
$1.14M 0.02%
+142,500
New +$793K
2022 Q4
0 quarters
SILK icon
523
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.08M 0.02%
20,530
-12,700
-38% -$619K
2022 Q1
3 quarters
SKIL icon
524
Skillsoft
SKIL
$51.6M
$1.08M 0.02%
41,682
– –
2021 Q2
6 quarters
CTLT icon
525
DELISTED
CATALENT, INC.
CTLT
$1.07M 0.02%
23,749
+15,949
+204% +$867K
2022 Q3
1 quarter
19 20
21
22 23

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.